Nanoviricides (NNVC) Liabilities and Shareholders Equity (2011 - 2026)
Nanoviricides (NNVC) reported Liabilities and Shareholders Equity of $9.87 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 11.9% from $8.82 million a year earlier but down 3.4% from the prior quarter.
Powered by 
Analysis
Nanoviricides (NNVC) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
Dating back to fiscal Q4 2011, Nanoviricides' Liabilities and Shareholders Equity record includes 61 quarters.
- Liabilities and Shareholders Equity has a five-year compound annual growth rate of -20.1% (FY2021 to FY2026).
- By fiscal year, Liabilities and Shareholders Equity came in at $8.82 million in FY2025 (-31.2%), $12.82 million in FY2024 (-24.1%), $16.9 million in FY2023 (-28.1%) and $23.49 million in FY2022 (-22.4%).
- Five-year quarterly Liabilities and Shareholders Equity spans a low of $8.36 million in fiscal Q1 2026 and a high of $29.18 million in fiscal Q1 2022.
- Year over year, Liabilities and Shareholders Equity has now increased in each of the last three quarters, with an average decline of 11.3% over the last eight quarters.
- The high point for year-over-year Liabilities and Shareholders Equity in five years was fiscal Q4 2026 (growth of 11.9%); the low point was fiscal Q3 2024 (a decline of 38.3%).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $10.22 million (Q3 2026), $12.27 million (Q2 2026) and $8.36 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Nanoviricides | 30.18 Mn | 17.84 Mn | - | 9.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.87 Mn |
| Mar 31, 2026 | 10.22 Mn |
| Dec 31, 2025 | 12.27 Mn |
| Sep 30, 2025 | 8.36 Mn |
| Jun 30, 2025 | 8.82 Mn |
| Mar 31, 2025 | 10.03 Mn |
| Dec 31, 2024 | 11.57 Mn |
| Sep 30, 2024 | 11.74 Mn |
| Jun 30, 2024 | 12.82 Mn |
| Mar 31, 2024 | 11.46 Mn |
| Dec 31, 2023 | 13.40 Mn |
| Sep 30, 2023 | 15.42 Mn |
| Jun 30, 2023 | 16.90 Mn |
| Mar 31, 2023 | 18.58 Mn |
| Dec 31, 2022 | 20.33 Mn |
| Sep 30, 2022 | 22.08 Mn |
| Jun 30, 2022 | 23.49 Mn |
| Mar 31, 2022 | 25.14 Mn |
| Dec 31, 2021 | 26.81 Mn |
| Sep 30, 2021 | 29.18 Mn |
API Access
Nanoviricides Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NNVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "NNVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NNVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();